Programmed death‐ligand 1 (PD‐L1), an immune checkpoint protein found on resident macrophages, immune, and tumour cells, is crucial in evaluating non‐small cell lung cancer (NSCLC) cases for immune checkpoint inhibitor (ICI) therapy. This evidence concerns the gene CD274 and neoplasm.